Holen Sie sich die Stockscreener-App
0.1502
3.03%
-0.0047
Handel nachbörslich:
.15
-0.0002
-0.13%
Schlusskurs vom Vortag:
$0.1549
Offen:
$0.1503
24-Stunden-Volumen:
1.05M
Relative Volume:
0.07
Marktkapitalisierung:
$3.19M
Einnahmen:
$12.43M
Nettoeinkommen (Verlust:
$-6.99M
KGV:
-0.0816
EPS:
-1.8409
Netto-Cashflow:
$-3.47M
1W Leistung:
-11.80%
1M Leistung:
-24.52%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.145
$0.156
1-Wochen-Bereich:
$0.145
$0.1838
52-Wochen-Spanne:
$0.145
$0.43
Reliance Global Group Inc Stock (EZRA) Company Profile
Firmenname
Reliance Global Group Inc
Sektor
Branche
Telefon
732-780-4647
Adresse
300 BOULEVARD OF THE AMERICAS,, LAKEWOOD
Compare EZRA vs MRSH, AON, AJG, WTW, BRO
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EZRA
Reliance Global Group Inc
|
0.1502 | 3.29M | 12.43M | -6.99M | -3.47M | -1.8409 |
MRSH
Marsh
|
163.39 | 77.85B | 27.55B | 4.01B | 4.93B | 7.9922 |
AON
Aon Plc
|
316.35 | 66.65B | 17.57B | 4.01B | 3.50B | 18.22 |
AJG
Arthur J Gallagher Co
|
197.40 | 51.02B | 14.97B | 1.62B | 1.86B | 6.1962 |
WTW
Willis Towers Watson Public Limited Co
|
251.44 | 23.59B | 9.90B | 1.68B | 1.57B | 17.08 |
BRO
Brown Brown Inc
|
55.77 | 18.76B | 6.40B | 1.15B | 1.43B | 3.1053 |
Reliance Global Group Inc Aktie (EZRA) Neueste Nachrichten
TradingKey - TradingKey
MSN Money - MSN
Reliance Global Group, Inc. (EZRA) Q1 2026 SEC 10-Q Report: Financials, Operations, and Key Highlights - Minichart
EZRA Should I Buy - Intellectia AI
Earnings call transcript: Reliance Global Q1 2026 focuses on financial improvement - Investing.com
Earnings call transcript: Reliance Global Q1 2026 focuses on financial improvement By Investing.com - Investing.com South Africa
Reliance Global : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Reliance Global (Nasdaq: EZRA) Q1 loss, capital raise and 1‑for‑40 reverse split - Stock Titan
Reliance Global Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Q1 2026 Reliance Global Group Inc Earnings Call Transcript - GuruFocus
Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments - The Manila Times
Cybersecurity, biotech push: Reliance lifts Enquantum stake to 29% - Stock Titan
リライアンス・グローバル・グループ、2026年第1四半期決算を発表し、Scale51戦略を技術・ライフサイエンス分野への戦略的投資で推進 - Moomoo
Reliance Global Shareholders Approve Governance and Equity Measures - TipRanks
Reliance Global Group elects directors and approves proposals at annual meeting - Investing.com Nigeria
Reliance Global Group (NASDAQ: EZRA) expands equity plan to 16M shares and clears share issuance cap - Stock Titan
Reliance Global Group Schedules First Quarter 2026 Financial Results and Business Update Conference Call - The Manila Times
Thursday at 4:30 p.m. ET: Reliance Global sets first-quarter call - Stock Titan
Reliance Global launches life sciences platform with Innervate investment By Investing.com - Investing.com
New Reliance life sciences unit starts with neuroblastoma-focused Innervate - Stock Titan
Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment - Yahoo! Finance Canada
Reliance Global Group Invests $2 Million in Innervate Radiopharmaceuticals to Expand Biotech Division and Advance Neuroblastoma Imaging Platform 1 - Minichart
Reliance Global Group Expands Into Radiopharmaceuticals with Investment - TipRanks
Reliance Global (NASDAQ: EZRA) invests $2M in Innervate radiopharma - Stock Titan
Reliance Global Forges Links with LifeSci Global - Baystreet.ca
Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA’s Biotech Division - The Manila Times
Reliance makes a $2M bet on childhood cancer imaging - Stock Titan
Reliance Global Group Completes Transformative Investment In Late-Stage Radiopharmaceutical Innovator Innervate Through Ezra’S Biotech Division - TradingView
EZRA Price Today: Reliance Global Group, Inc. Stock Price, Quote & Chart | MEXC - MEXC
[424B3] Reliance Global Group, Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
[EFFECT] Reliance Global Group, Inc. SEC Filing - Stock Titan
Reliance Global (EZRA) Boosts Stake in Enquantum to Nearly 29% - GuruFocus
Reliance Global increases Enquantum stake to 29% By Investing.com - Investing.com Australia
Reliance Global Group Increases Stake in Enquantum to 29% as Post-Quantum Cybersecurity Investment Advances Toward Control - citybiz
Reliance Global increases Enquantum stake to 29% - Investing.com
Reliance Global Group Increases Ownership in Enquantum to 29% Following Achievement of Defined Technical and Commercial Milestones - The Manila Times
XRP treasury holdings top $11.5B as Reliance Global adds token to reserves - MSN
Reliance Global files to sell 4.57M shares for holders - MSN
RELI Price Today: Reliance Global Group, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Reliance Global Group (NASDAQ: EZRA) confirms January financing, warrant coverage - Stock Titan
Reliance (EZRA) Stock Sentiment Analysis (Drifts Lower) 2026-04-20Most Discussed Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Reliance Global Group, Inc. (RELIW) - Minichart
Reliance Global Group, Inc. (EZRAW) - Minichart
RELIANCE GLOBAL GROUP, INC. (EZRA) - MSN
Reliance Global Group to Participate in Centri Capital Conference at Nasdaq MarketSite in New York City on April 14, 2026 - TMX Newsfile
Reliance Global launches updated insurtech platform, RELI Exchange 2.0 - Reinsurance News
Portfolio Shifts: Should I average down on Reliance Global Group Inc stockRecession Risk & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Finanzdaten der Reliance Global Group Inc-Aktie (EZRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):